BioKier Obtains $1,700,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    PO Box 3855 Chapel Hill, NC 27515 USA
  • Company Description
    BioKier Inc. is an early-stage pharmaceutical company developing new proprietary drugs for diabetes and related disorders. BioKier has identified a therapeutic opportunity and is developing a novel treatment for type 2 diabetes. This treatment will potentially also have effects in metabolic syndrome and obesity.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy